Bryn Mawr Capital Management LLC Boosts Position in The Chemours Company (NYSE:CC)

Bryn Mawr Capital Management LLC boosted its holdings in The Chemours Company (NYSE:CCFree Report) by 135.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 27,205 shares of the specialty chemicals company’s stock after buying an additional 15,662 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Chemours were worth $858,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. Deutsche Bank AG raised its stake in shares of Chemours by 4,407.9% during the third quarter. Deutsche Bank AG now owns 1,759,419 shares of the specialty chemicals company’s stock valued at $49,352,000 after purchasing an additional 1,720,389 shares during the period. Anchor Investment Management LLC purchased a new stake in shares of Chemours during the fourth quarter valued at approximately $56,000. Assenagon Asset Management S.A. purchased a new stake in shares of Chemours during the fourth quarter valued at approximately $4,711,000. American Century Companies Inc. raised its stake in shares of Chemours by 0.7% during the third quarter. American Century Companies Inc. now owns 1,459,463 shares of the specialty chemicals company’s stock valued at $40,938,000 after purchasing an additional 10,075 shares during the period. Finally, Sherbrooke Park Advisers LLC purchased a new stake in shares of Chemours during the third quarter valued at approximately $1,044,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on CC shares. Barclays dropped their price target on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. BMO Capital Markets upgraded shares of Chemours from an “underperform” rating to an “outperform” rating and lifted their price target for the stock from $19.00 to $34.00 in a research note on Tuesday, April 9th. Finally, UBS Group lifted their price target on shares of Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 2nd. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $30.89.

Check Out Our Latest Stock Analysis on Chemours

Chemours Stock Performance

Chemours stock opened at $27.32 on Friday. The company has a fifty day moving average price of $26.72 and a two-hundred day moving average price of $27.79. The company has a quick ratio of 1.00, a current ratio of 1.54 and a debt-to-equity ratio of 5.40. The Chemours Company has a 12 month low of $15.10 and a 12 month high of $39.05.

Chemours (NYSE:CCGet Free Report) last released its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. On average, equities analysts anticipate that The Chemours Company will post 2.23 earnings per share for the current fiscal year.

Chemours Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 3.66%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s dividend payout ratio (DPR) is -64.52%.

Chemours Company Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Articles

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.